Edward Joseph Gudaitis - Net Worth and Insider Trading
Edward Joseph Gudaitis Net Worth
The estimated net worth of Edward Joseph Gudaitis is at least $28,614 dollars as of 2024-09-21. Edward Joseph Gudaitis is the Director, Senior Officer of Acerus Pharmaceuticals Corp and owns about 79,482 shares of Acerus Pharmaceuticals Corp (TSX:ASP) stock worth over $28,614. Details can be seen in Edward Joseph Gudaitis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edward Joseph Gudaitis has not made any transactions after 2022-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Edward Joseph Gudaitis
Edward Joseph Gudaitis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edward Joseph Gudaitis owns 1 companies in total, including Acerus Pharmaceuticals Corp (TSX:ASP) .
Click here to see the complete history of Edward Joseph Gudaitis’s form 4 insider trades.
Insider Ownership Summary of Edward Joseph Gudaitis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:ASP | Acerus Pharmaceuticals Corp | 2022-05-11 | Director & Senior Officer |
Edward Joseph Gudaitis Latest Holdings Summary
Edward Joseph Gudaitis currently owns a total of 1 stock. Edward Joseph Gudaitis owns 79,482 shares of Acerus Pharmaceuticals Corp (TSX:ASP) as of May 11, 2022, with a value of $28,614.
Latest Holdings of Edward Joseph Gudaitis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:ASP | Acerus Pharmaceuticals Corp | 2022-05-11 | 79,482 | 0.36 | 28,614 |
Holding Weightings of Edward Joseph Gudaitis
Edward Joseph Gudaitis Form 4 Trading Tracker
According to the SEC Form 4 filings, Edward Joseph Gudaitis has made a total of 2 transactions in Acerus Pharmaceuticals Corp (TSX:ASP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Acerus Pharmaceuticals Corp is the acquisition of 500 shares on May 11, 2022, which cost Edward Joseph Gudaitis around $2,260.
Insider Trading History of Edward Joseph Gudaitis
- 1
Edward Joseph Gudaitis Trading Performance
GuruFocus tracks the stock performance after each of Edward Joseph Gudaitis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edward Joseph Gudaitis is -6.28%. GuruFocus also compares Edward Joseph Gudaitis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edward Joseph Gudaitis within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Edward Joseph Gudaitis's insider trading performs compared to the benchmark.
Performance of Edward Joseph Gudaitis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.73 | | | | | |
| Relative Return to S&P 500(%) | -12.48 | | | | | |
Edward Joseph Gudaitis Ownership Network
Edward Joseph Gudaitis Owned Company Details
What does Acerus Pharmaceuticals Corp do?
Who are the key executives at Acerus Pharmaceuticals Corp?
Edward Joseph Gudaitis is the Director & Senior Officer of Acerus Pharmaceuticals Corp. Other key executives at Acerus Pharmaceuticals Corp include and Senior Officer Robert Martin Motz .
Acerus Pharmaceuticals Corp (TSX:ASP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acerus Pharmaceuticals Corp (TSX:ASP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acerus Pharmaceuticals Corp (TSX:ASP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acerus Pharmaceuticals Corp (TSX:ASP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acerus Pharmaceuticals Corp Insider Transactions
Edward Joseph Gudaitis Mailing Address
Above is the net worth, insider trading, and ownership report for Edward Joseph Gudaitis. Currently GuruFocus does not have mailing address information for Edward Joseph Gudaitis.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
